Search Results - "Hekster, Y.A."

Refine Results
  1. 1
  2. 2

    Effectiveness of lamotrigine in clinical practice: Results of a retrospective population-based study by Knoester, P.D., Keyser, A., Renier, W.O., Egberts, A.C.G., Hekster, Y.A., Deckers, C.L.P.

    Published in Epilepsy research (01-06-2005)
    “…Evaluation of the effectiveness of lamotrigine in a population-based cohort of epilepsy patients. Medical charts of 360 patients treated in 37 centres in The…”
    Get full text
    Journal Article
  3. 3

    Cost-effectiveness of add-on lamotrigine therapy in clinical practice by Knoester, P.D., Boendermaker, A.J., Egberts, A.C.G., Hekster, Y.A., Keyser, A., Severens, J.L., Renier, W.O., Deckers, C.L.P.

    Published in Epilepsy research (01-12-2005)
    “…This retrospective study addresses the cost-effectiveness of add-on therapy with lamotrigine in clinical practice. Two years’ observational data of 165…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Off-Label Use of Drugs in Pain Medicine and Palliative Care: An Algorithm for the Assessment of its Safe and Legal Prescription by Verhagen, Constans C. A. H. H. V. M., Niezink, Anne G. H., Engels, Yvonne Y, Hekster, Yechiel Y. A., Doornebal, Joan J., Vissers, Kris C. P.

    Published in Pain practice (01-05-2008)
    “…▪   Off‐label medication use is common practice, particularly in difficult to treat patients who have already tried commonly accepted medication…”
    Get full text
    Journal Article
  6. 6

    Epilepsy treatment in The Netherlands. Comparison of matched groups of two medical centres by Lammers, M W, Wijsman, D J, Hekster, Y A, Keyser, A, Renier, W O, Meinardi, H, van Lier, H

    Published in Acta neurologica Scandinavica (01-06-1994)
    “…To test the feasibility of comparing epilepsy treatment policies and outcome, a secondary and a tertiary epilepsy care facility have been audited in a previous…”
    Get more information
    Journal Article
  7. 7

    High-performance liquid chromatography of HIV protease inhibitors in human biological matrices by Aarnoutse, R.E, Verweij-van Wissen, C.P.W.G.M, Underberg, W.J.M, Kleinnijenhuis, J, Hekster, Y.A, Burger, D.M

    “…Methods for HPLC analysis of protease inhibitors (PIs) in human biological matrices were reviewed. Assays have been developed for analysis of single PIs or for…”
    Get full text
    Book Review Journal Article
  8. 8

    Novel oxidative pathways of sulphapyridine and sulphadiazine by the turtle Pseudemys scripta elegans by Vree, T B, Vree, J B, Beneken Kolmer, E W, Hekster, Y A

    Published in The Veterinary quarterly (01-10-1991)
    “…The sulphonamides sulphapyridine and sulphadiazine show novel hydroxy metabolites in the turtle Pseudemys scripta elegans. In the excreta of the turtles the…”
    Get more information
    Journal Article
  9. 9

    Determination of nevirapine, an HIV-1 non-nucleoside reverse transcriptase inhibitor, in human plasma by reversed-phase high-performance liquid chromatography by Hollanders, R.M.F, van Ewijk-Beneken Kolmer, E.W.J, Burger, D.M, Wuis, E.W, Koopmans, P.P, Hekster, Y.A

    “…A sensitive and rapid high-performance liquid chromatography method has been developed to measure the levels of the HIV-1 non-nucleoside reverse transcriptase…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Determination of trimethoprim and sulfamethoxazole (co-trimoxazole) in body fluids of man by means of high-performance liquid chromatography by Vree, T B, Hekster, Y A, Baars, A M, Damsma, J E, Kleijin, E V

    Published in Journal of chromatography (01-07-1978)
    “…A high-performance liquid chromatographic method for the determination of trimethoprim, sulfamethoxazole and its metabolite and a series of structurally…”
    Get more information
    Journal Article
  12. 12
  13. 13

    Determination of indinavir, an HIV-protease inhibitor, in human plasma by reversed-phase high-performance liquid chromatography by Burger, D.M, de Graaff, M, Wuis, E.W, Koopmans, P.P, Hekster, Y.A

    “…A sensitive high-performance liquid chromatographic assay has been developed to determine the concentrations of the HIV-protease inhibitor indinavir in human…”
    Get full text
    Journal Article
  14. 14

    O-Dealkylation and N4-acetylation of sulpha-2-monomethoxine by the turtle Pseudemys scripta elegans by Vree, T B, Vree, M L, Beneken Kolmer, E W, Hekster, Y A, Shimoda, M, Ono, M, Miura, T

    Published in The Veterinary quarterly (01-07-1991)
    “…Sulpha-2-monomethoxine is N4-acetylated to an extent of 12% of the dose by Pseudemys scripta elegans; 48% is excreted unchanged. No O-dealkylation of the…”
    Get more information
    Journal Article
  15. 15

    O-demethylation and N4-acetylation of sulphadimethoxine by the turtle Pseudemys scripta elegans by Vree, T B, Vree, J B, Beneken Kolmer, N, Hekster, Y A, Shimoda, M, Nouws, J F, Yoshioka, T, Hoji, K

    Published in The Veterinary quarterly (01-07-1989)
    “…After an oral dose of 350 mg of sulphadimethoxine, the turtle Pseudemys scripta elegans O-dealkylates sulphadimethoxine at the 2- and 6-position at 38% and 19%…”
    Get more information
    Journal Article
  16. 16
  17. 17
  18. 18

    Oxidation and O-dealkylation of sulphamonomethoxine by the turtle Pseudemys scripta elegans by Vree, T B, Vree, J B, Beneken Kolmer, N, Hekster, Y A, Shimoda, M, Nouws, J F, Yoshioka, T, Hoji, K

    Published in The Veterinary quarterly (01-07-1989)
    “…Sulphamonomethoxine is O-demethylated at the 6 position and oxidised at the 2 position of the pyrimidine substituent by Pseudemys scripta elegans. No…”
    Get more information
    Journal Article
  19. 19

    N-oxidation, O-demethylation, and excretion of trimethoprim by the turtle Pseudemys scripta elegans by Vree, T B, Vree, J B, Kolmer, E B, Hekster, Y A, Nouws, J F, Shimoda, M

    Published in The Veterinary quarterly (01-04-1989)
    “…Trimethoprim was excreted within one hour after being given orally to the turtle Pseudemys scripta elegans. No O-demethylated or N-oxide metabolites were…”
    Get more information
    Journal Article
  20. 20